Stocks Near Their 52-Week High — Financial View · Healthcare
172 stocks match the Stocks Near Their 52-Week High screen. Stocks trading within 10% of their 52-week high — momentum/breakout candidates, largest first. Financial columns. Filtered to Healthcare. Updated
Filters2
1–100 of 100
| JNJ | Johnson & Johnson | $670.6B | 1.9% | 10.5% | 24.8% | 17.2% | 1.09 | 0.44 | 67.9% | 22.0% | 21.5% | 278.28 | +1.04% | 216K |
| ONC | Beone Medicines Ltd. | $535.9B | — | 7.1% | 12.7% | 11.0% | 3.40 | 0.15 | 88.9% | 15.1% | 10.7% | 362.54 | +0.23% | 14K |
| ABBV | AbbVie | $459.8B | 2.6% | 4.7% | — | 10.8% | 0.81 | -10.87 | 71.5% | 26.2% | 9.8% | 260.21 | -0.57% | 120K |
| MRK | Merck | $375.8B | 2.2% | 2.4% | 7.6% | 3.4% | 1.32 | 1.22 | 73.0% | — | 4.8% | 152.32 | +0.44% | 324K |
| AMGN | Amgen | $240.1B | 2.2% | 9.1% | 74.8% | 12.7% | 1.37 | 4.90 | 69.5% | 30.0% | 23.0% | 444.20 | +0.31% | 69K |
| TMO | Thermo Fisher Scientific | $228.7B | 0.3% | 6.2% | 13.2% | 7.3% | 1.55 | 0.80 | — | 17.6% | 15.0% | 618.50 | +1.66% | 88K |
| GILD | Gilead Sciences | $187.5B | 2.1% | -6.6% | -27.4% | -8.5% | 1.27 | 2.22 | 79.6% | -8.2% | -10.6% | 151.21 | +1.09% | 186K |
| PFE | Pfizer | $164.2B | 6.0% | 2.2% | 5.1% | 3.0% | 1.27 | 0.71 | 73.2% | — | 6.8% | 28.81 | -0.76% | 1.8M |
| VRTX | Vertex Pharmaceuticals | $141.5B | — | 16.1% | 21.8% | 21.6% | 3.19 | 0.01 | 86.0% | 38.0% | 35.0% | 558.12 | +0.24% | 45K |
| BMY | Bristol Myers Squibb | $139.1B | 3.7% | 10.6% | 41.6% | 14.2% | 1.53 | 1.92 | 70.2% | — | 18.9% | 68.08 | +0.62% | 338K |
| REGN | Regeneron Pharmaceuticals | $87.2B | 0.4% | 10.4% | 13.7% | 12.8% | 3.34 | 0.06 | — | 24.7% | 27.9% | 843.50 | -1.02% | 28K |
| MMM | 3M | $86.8B | 1.8% | 8.6% | — | 21.6% | 1.24 | 3.69 | 39.4% | 18.4% | 11.9% | 168.35 | -0.28% | 138K |
| EW | Edwards Lifesciences | $51.7B | — | 7.2% | 9.5% | 9.0% | 4.52 | 0.06 | 77.8% | 22.3% | 15.4% | 89.78 | -1.16% | 83K |
| NTRA | Natera, Inc. | $47.2B | — | -7.2% | -10.6% | -9.1% | 3.00 | 0.16 | — | -10.7% | -7.1% | 327.28 | +0.66% | 33K |
| RVMD | Revolution Medicines, Inc. | $45.2B | — | -40.9% | -67.8% | -67.8% | 11.38 | 0.66 | — | — | — | 210.79 | +0.76% | 72K |
| TEVA | Teva Pharmaceutical Industries Ltd | $42.6B | 13.5% | 1.8% | 9.1% | 1.9% | 0.88 | 3.72 | 52.5% | 9.3% | 4.1% | 36.60 | -2.32% | 166K |
| A | Agilent Technologies | $42.3B | 0.7% | 10.3% | 19.6% | 13.1% | 2.05 | 0.50 | 53.8% | 22.2% | 19.5% | 149.91 | -0.93% | 176K |
| WAT | Waters Corporation | $40.6B | — | 2.6% | 4.2% | 3.2% | 1.86 | 0.32 | 25.8% | 7.1% | 13.8% | 413.64 | +0.36% | 27K |
| DXCM | DexCom | $33.9B | — | 15.5% | 38.1% | 38.1% | 1.73 | 0.00 | 62.5% | 22.9% | 20.1% | 89.71 | +0.02% | 82K |
| ILMN | Illumina, Inc. | $33.5B | — | 12.4% | 29.1% | 23.5% | 1.80 | 0.24 | 66.4% | 19.6% | 18.4% | 221.69 | +3.90% | 159K |
| BIIB | Biogen | $33.1B | — | 4.7% | 7.4% | 5.5% | 3.06 | 0.34 | 75.5% | 28.6% | 13.8% | 224.49 | +0.78% | 32K |
| RPRX | Royalty Pharma Plc | $28.2B | 1.4% | 4.1% | 8.3% | 4.3% | 2.80 | 0.92 | — | 59.6% | 32.1% | 63.88 | +1.24% | 205K |
| LH | Labcorp | $26.9B | 0.9% | 5.4% | 11.6% | 6.9% | 1.80 | 0.68 | 28.9% | 10.4% | 7.0% | 331.48 | -0.07% | 28K |
| DGX | Quest Diagnostics | $26.4B | 1.4% | 6.3% | 14.1% | 8.1% | 1.59 | 0.75 | 33.1% | 14.1% | 9.2% | 239.37 | -0.58% | 45K |
| GH | Guardant Health, Inc. | $21.6B | — | -23.7% | — | -35.4% | 4.03 | -6.74 | 65.0% | -39.7% | -38.3% | 161.01 | -1.23% | 73K |
| THC | Tenet Healthcare Corp | $21.2B | — | 10.3% | 68.1% | 36.2% | 1.41 | 0.88 | — | 20.8% | 14.6% | 263.48 | +1.89% | 36K |
| VTRS | Viatris | $19.5B | 2.8% | -10.0% | -24.6% | -13.6% | 1.58 | 0.81 | 34.9% | -0.6% | -23.9% | 16.94 | -0.88% | 380K |
| ZBH | Zimmer Biomet | $18.9B | 1.0% | 3.5% | 6.4% | 4.3% | 1.69 | 0.50 | 69.9% | 14.2% | 9.5% | 98.88 | -0.60% | 92K |
| JAZZ | Jazz Pharmaceuticals Plc | $16.1B | — | 8.5% | 19.6% | 10.3% | 1.78 | 0.91 | — | 19.5% | 20.4% | 247.64 | +0.86% | 41K |
| SOLV | Solventum | $15.7B | — | 10.1% | 29.9% | 15.3% | 1.02 | 0.95 | 54.7% | 25.0% | 17.3% | 92.44 | +0.56% | 38K |
| EXEL | Exelixis, Inc. | $14.7B | — | 34.5% | 46.7% | 46.7% | 3.46 | 0.00 | 96.5% | 39.9% | 35.3% | 59.13 | +1.00% | 116K |
| RVTY | Revvity | $14.6B | 0.2% | 2.0% | 3.3% | 2.4% | 1.80 | 0.36 | 68.3% | 12.3% | 8.2% | 130.64 | -0.24% | 90K |
| BMRN | Biomarin Pharmaceutical Inc | $12.9B | — | 0.6% | 1.2% | 0.7% | 2.39 | 0.66 | 76.1% | 4.4% | 2.1% | 66.42 | -0.87% | 115K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | — | 16.0% | — | 19.9% | 2.71 | 13.50 | 82.4% | 35.9% | 24.9% | 110.73 | +1.01% | 90K |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.2B | — | -15.1% | -68.7% | -68.7% | 5.90 | — | — | -33.8% | -47.8% | 86.53 | +1.34% | 76K |
| EHC | Encompass Health Corp | $12.1B | 0.6% | 8.3% | 23.9% | 16.3% | 1.19 | 0.47 | — | 8.7% | 10.0% | 122.64 | +1.19% | 34K |
| TECH | Bio-Techne | $11.4B | 0.4% | 7.0% | 8.6% | 8.6% | 4.55 | — | 65.8% | 20.7% | 15.0% | 72.46 | +0.21% | 124K |
| KRYS | Krystal Biotech, Inc. | $11.0B | — | 16.1% | 17.8% | 17.7% | 8.32 | 0.00 | — | 44.9% | 54.8% | 371.35 | +0.58% | 14K |
| GKOS | Glaukos Corp | $10.6B | — | -20.4% | -27.6% | -27.4% | 5.04 | 0.00 | 60.7% | -31.6% | -30.7% | 180.41 | +0.52% | 40K |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | — | 2.2% | 3.1% | 2.7% | 3.14 | 0.17 | 51.9% | 2.1% | 8.6% | 387.70 | -0.19% | 9K |
| AVTR | Avantor, Inc. | $10.4B | — | -4.7% | -9.9% | -5.9% | 1.76 | 0.68 | 32.1% | -4.5% | -8.4% | 15.20 | +3.65% | 718K |
| APGE | Apogee Therapeutics, Inc. | $10.2B | — | -22.0% | — | — | 26.44 | — | — | — | — | 135.08 | +0.04% | 89K |
| PRAX | Praxis Precision Medicines, Inc. | $9.9B | — | -24.4% | -25.3% | -25.3% | 15.73 | 0.04 | — | — | — | 354.92 | -0.78% | 14K |
| KYMR | Kymera Therapeutics, Inc. | $9.7B | — | -18.2% | -19.9% | -19.9% | 10.34 | 0.09 | 0.0% | — | — | 117.15 | -1.24% | 40K |
| PTGX | Protagonist Therapeutics, Inc | $9.6B | — | 9.4% | 9.9% | 9.7% | 21.71 | 0.01 | — | — | — | 148.74 | +1.90% | 21K |
| PCVX | Vaxcyte, Inc. | $9.1B | 0.0% | -33.9% | -38.6% | -38.6% | 5.72 | 0.14 | — | — | — | 61.22 | -0.62% | 43K |
| BRKR | Bruker Corp | $9.1B | 0.3% | -1.2% | -3.0% | -1.7% | 1.85 | 0.76 | 46.4% | -0.9% | -2.0% | 59.41 | +0.61% | 88K |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.0B | — | -37.9% | -42.1% | -42.1% | 15.57 | 0.11 | — | — | — | 84.96 | +0.13% | 161K |
| TGTX | Tg Therapeutics, Inc. | $8.7B | — | 26.9% | 73.1% | 32.7% | 4.27 | 1.23 | 82.4% | 17.1% | 55.2% | 56.69 | -0.42% | 75K |
| TXG | 10x Genomics, Inc. | $8.2B | — | -7.3% | -9.1% | -9.1% | 5.69 | 0.00 | 70.0% | -14.3% | -12.2% | 63.16 | +2.45% | 128K |
| MSA | Msa Safety Inc | $7.2B | 1.1% | 12.1% | 22.4% | 15.7% | 3.24 | 0.43 | 47.6% | 21.2% | 16.1% | 187.84 | -0.34% | 23K |
| CHE | Chemed Corp | $6.9B | 0.4% | 17.4% | 33.1% | 28.3% | 0.91 | 0.17 | 33.1% | 13.5% | 10.6% | 525.28 | +0.21% | 5K |
| SRRK | Scholar Rock Holding Corp | $6.8B | — | -78.0% | — | -90.8% | 7.02 | 0.77 | — | — | — | 55.91 | -0.42% | 48K |
| MMED | Minimed Group, Inc. | $6.7B | — | -7.1% | -9.2% | -9.2% | 1.81 | 0.30 | 54.2% | -6.1% | -10.7% | 23.83 | +0.42% | 149K |
| LNTH | Lantheus Holdings, Inc. | $6.6B | — | 11.4% | 21.0% | 14.7% | 3.06 | 0.43 | 60.1% | 19.4% | 17.7% | 100.98 | +0.17% | 44K |
| CGON | Cg Oncology, Inc. | $6.6B | — | -20.7% | -21.8% | -21.7% | 22.22 | 0.00 | — | — | — | 74.31 | -0.41% | 31K |
| BLCO | Bausch & Lomb Corp | $6.5B | — | -1.2% | -2.7% | -1.5% | 1.55 | 0.80 | — | 6.1% | -3.2% | 18.14 | +0.72% | 15K |
| TVTX | Travere Therapeutics, Inc. | $6.3B | — | -5.4% | — | -61.6% | 4.05 | 1.88 | 98.6% | -6.8% | -7.4% | 66.50 | -1.06% | 68K |
| KNSA | Kiniksa Pharmaceuticals International, Plc | $6.2B | — | 8.9% | 12.1% | 12.1% | 3.79 | 0.36 | 89.3% | 12.4% | 9.7% | 80.42 | +0.65% | 46K |
| DNTH | Dianthus Therapeutics, Inc. /De/ | $6.0B | 0.0% | -15.8% | -16.4% | -16.4% | 26.10 | 0.04 | — | — | — | 107.74 | +1.25% | 28K |
| TFX | Teleflex Inc | $5.9B | 1.0% | -15.2% | -35.5% | -18.1% | 2.60 | 0.97 | 54.9% | 2.0% | -45.8% | 139.91 | -0.78% | 79K |
| SHC | Sotera Health Co | $5.4B | — | 4.9% | 24.6% | 5.8% | 2.80 | 3.21 | 55.0% | 24.5% | 13.4% | 19.04 | +0.37% | 135K |
| MMSI | Merit Medical Systems Inc | $5.3B | — | 5.1% | 8.7% | 6.0% | 4.20 | 0.44 | 49.5% | 12.8% | 9.2% | 88.50 | -1.84% | 52K |
| PBLS | Parabilis Medicines, Inc. | $5.0B | — | — | — | — | 17.91 | 0.00 | — | — | — | 40.74 | +1.57% | 14K |
| LFST | Lifestance Health Group, Inc. | $4.9B | — | 2.3% | 3.4% | 2.9% | 1.38 | 0.19 | — | 4.9% | 3.2% | 12.83 | -0.47% | 338K |
| HAE | Haemonetics Corp | $4.7B | — | 4.1% | 11.5% | 4.8% | 3.08 | 1.42 | 59.0% | 11.9% | 7.1% | 102.81 | -0.21% | 36K |
| DYN | Dyne Therapeutics, Inc. | $4.7B | — | -52.3% | -74.0% | -57.6% | 12.02 | 0.28 | — | — | — | 24.93 | -0.80% | 204K |
| LIVN | Livanova Plc | $4.5B | — | 7.1% | 14.2% | 11.7% | 1.45 | 0.22 | 68.1% | 12.7% | 12.8% | 81.22 | -1.46% | 71K |
| NVST | Envista Holdings Corp | $4.4B | — | 1.7% | 3.1% | 2.1% | 2.43 | 0.47 | 55.2% | 9.6% | 3.3% | 27.60 | +0.73% | 250K |
| CON | Concentra Group Holdings Parent, Inc. | $4.4B | 0.7% | 6.6% | 41.7% | 41.7% | 1.38 | 5.25 | — | 16.4% | 8.7% | 34.53 | +1.41% | 40K |
| ELVN | Enliven Therapeutics, Inc. | $4.4B | — | -11.6% | -11.8% | -11.8% | 64.07 | 0.02 | — | — | — | 59.61 | +0.98% | 26K |
| HTFL | Heartflow, Inc. | $4.3B | — | -34.4% | -42.3% | -42.3% | 5.08 | 0.23 | 80.1% | -37.8% | -55.8% | 49.69 | -0.60% | 85K |
| ITGR | Integer Holdings Corp | $4.3B | — | 3.8% | 7.5% | 4.3% | 3.73 | 0.72 | 25.7% | 9.7% | 7.0% | 125.50 | +0.16% | 52K |
| IOVA | Iovance Biotherapeutics, Inc. | $4.0B | — | -31.6% | -39.3% | -39.3% | 4.35 | 0.24 | 48.4% | -92.7% | -89.1% | 8.80 | +2.09% | 641K |
| ADPT | Adaptive Biotechnologies Corp | $3.9B | — | -10.0% | -44.7% | -44.7% | 4.79 | 0.00 | 75.6% | -12.2% | -20.7% | 24.57 | -0.34% | 108K |
| PLSE | Pulse Biosciences, Inc. | $3.9B | — | -69.3% | -80.5% | -80.5% | 9.63 | 0.16 | 0.3% | — | — | 54.66 | +3.79% | 32K |
| IDYA | Ideaya Biosciences, Inc. | $3.9B | — | -13.4% | -14.6% | -14.6% | 10.45 | 0.09 | — | -92.7% | -74.8% | 39.97 | -0.45% | 36K |
| RCUS | Arcus Biosciences, Inc. | $3.8B | — | -49.8% | -99.1% | -81.4% | 3.82 | 0.22 | — | — | — | 30.12 | +1.09% | 37K |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.6B | 0.0% | -7.6% | -13.4% | -11.1% | 3.20 | 0.21 | — | -8.0% | -7.7% | 83.12 | +0.41% | 43K |
| OGN | Organon & Co. | $3.6B | 0.6% | 1.6% | 20.8% | 2.2% | 1.95 | 8.50 | 52.7% | — | 3.4% | 13.78 | +0.00% | 148K |
| ABCL | Abcellera Biologics Inc. | $3.5B | — | -12.6% | -18.4% | -18.4% | 12.77 | 0.46 | — | — | — | 11.56 | +1.76% | 251K |
| NHC | National Healthcare Corp | $3.5B | 1.2% | 9.1% | 12.5% | 12.5% | 1.86 | 0.00 | — | 9.3% | 9.0% | 221.63 | +1.66% | 3K |
| IMNM | Immunome Inc. | $3.1B | — | -45.0% | -48.4% | -48.4% | 15.08 | 0.00 | — | — | — | 27.16 | -0.48% | 36K |
| AVAH | Aveanna Healthcare Holdings, Inc. | $3.0B | — | 0.0% | 0.1% | 0.0% | 1.16 | 4.52 | 33.3% | 10.5% | 0.0% | 13.64 | +3.33% | 92K |
| ATRC | Atricure, Inc. | $2.7B | — | 1.6% | 2.0% | 1.8% | 4.22 | 0.12 | 76.3% | 2.3% | 1.9% | 52.46 | -0.28% | 74K |
| BCRX | Biocryst Pharmaceuticals Inc | $2.6B | — | -69.0% | — | — | 2.32 | -0.87 | 97.8% | -33.3% | -40.9% | 10.10 | -0.79% | 151K |
| PGEN | Precigen, Inc. | $2.6B | — | -92.6% | — | — | 4.58 | 2.15 | — | — | — | 7.13 | +1.78% | 153K |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.4B | — | 13.2% | 18.1% | 15.7% | 3.48 | 0.15 | 75.4% | 24.0% | 18.9% | 41.85 | -2.39% | 72K |
| SRPT | Sarepta Therapeutics, Inc. | $2.4B | — | -4.3% | -8.9% | -5.8% | 4.42 | 0.55 | — | -10.2% | -9.8% | 22.99 | -0.95% | 180K |
| TRLV | Trulieve Cannabis Corp. | $2.3B | — | -22.9% | -62.2% | -49.5% | 5.94 | 0.26 | 59.5% | -24.3% | -41.8% | 12.02 | +2.56% | 70K |
| PVLA | Palvella Therapeutics, Inc. | $2.2B | — | -24.3% | -28.4% | -28.4% | 21.18 | 0.17 | — | — | — | 155.41 | +1.35% | 14K |
| ADUS | Addus Homecare Corp | $2.2B | — | 7.2% | 9.2% | 8.7% | 1.69 | 0.05 | 32.4% | 10.0% | 7.1% | 118.67 | +0.39% | 12K |
| MD | Pediatrix Medical Group, Inc. | $2.2B | — | 8.2% | 19.8% | 11.7% | 1.32 | 0.69 | — | 11.0% | 9.0% | 26.86 | -0.02% | 25K |
| ZYME | Zymeworks Inc. | $2.1B | — | -37.8% | — | — | 6.32 | 3.94 | — | — | — | 29.89 | -3.70% | 26K |
| BLFS | Biolife Solutions Inc | $1.7B | — | 13.0% | 13.8% | 13.8% | 9.69 | 0.00 | 60.4% | 2.9% | 56.4% | 35.52 | -1.15% | 42K |
| ETON | Eton Pharmaceuticals, Inc. | $1.7B | — | 11.0% | 27.2% | 19.3% | 1.52 | 0.41 | 57.9% | 15.4% | 12.0% | 59.88 | -3.43% | 18K |
| LBRX | LB PHARMACEUTICALS INC | $1.5B | — | -23.7% | -25.8% | -25.8% | 15.08 | 0.09 | — | — | — | 47.51 | -3.98% | 8K |
| REPL | Replimune Group, Inc. | $1.4B | — | — | — | — | 5.23 | 0.80 | — | — | — | 15.28 | -4.32% | 50K |
| CGEM | Cullinan Therapeutics, Inc. | $1.4B | — | -56.3% | -63.6% | -63.6% | 8.42 | 0.13 | — | — | — | 22.16 | -0.81% | 19K |
| ANRO | Alto Neuroscience, Inc. | $1.4B | — | -33.2% | -38.4% | -36.4% | 14.85 | 0.06 | — | — | — | 36.33 | -0.81% | 13K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.